Les substances allergènes proviennent principalement des parfums incorporés dans les formules, mais on en trouve aussi dans les conservateurs. Les molécules susceptibles de provoquer une réaction ...

Q. When working in pediatric medicine several years ago, I remember a 3-year-old child who became psychotic because a child psychiatrist gave him methylphenidate (Ritalin). The child did not sleep for ...

Q. When working in pediatric medicine several years ago, I remember a 3-year-old child who became psychotic because a child psychiatrist gave him methylphenidate (Ritalin). The child did not sleep for ...

Q. When working in pediatric medicine several years ago, I remember a 3-year-old child who became psychotic because a child psychiatrist gave him methylphenidate (Ritalin). The child did not sleep for ...

Revenue from Vaxini was pressured by lower average selling prices linked to higher rebates and 340B discounts; these pricing headwinds are expected to persist in the near term according to management ...

RANCHO CUCAMONGA, CA / ACCESS Newswire / May 6, 2026 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO, and Tony Marrs, EVP of Regulatory Affairs and Clinical ...

Amphastar Pharmaceuticals trades at a deep discount—6.7x trailing earnings—reflecting structural growth and margin challenges. Branded product growth (BAQSIMI, Primatene MIST) has not offset ...

When it comes to hairstyles, there are the age-old spirals: debating a bob, flirting with bangs (often after a breakup), or committing to growing it all out. But when it comes to 2026-specific trends, ...

Please provide your email address to receive an email when new articles are posted on . Risk for first moderate/severe COPD exacerbation was lower among dry powder vs. metered-dose or soft mist ...

Amphastar Pharmaceuticals is rated a Buy, with ~81% upside to a $33 fair value, despite margin pressures for 2026. AMPH faces declining sales in legacy products but expects mid- to high-single-digit ...

New research from UCLA Health suggests that certain inhalers used to treat chronic obstructive pulmonary disease (COPD) are not only less harmful to the environment but can also lead to slightly ...